Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
A phase 3 trial of Piflufolastat F-18 / Pylarify TruVu in Prostate cancer, run by Progenics Pharmaceuticals, Inc., completed.
Overview
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer is a phase 3 interventional study registered as NCT03739684 by Progenics Pharmaceuticals, Inc., with 208 participants recorded, started 2018-11-27 and reaching its primary completion in 2019-08-29. Interventions recorded: 18F-DCFPyL, PET/CT Imaging. Conditions recorded: Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Recurrent, Prostate Cancer Metastatic.
Linked to the drug Piflufolastat F-18 / Pylarify TruVu because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStudy of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
Shares Piflufolastat F-18 / Pylarify TruVu, Lantheus, Prostate cancer and the tag pipeline.
- TrialRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
Shares Piflufolastat F-18 / Pylarify TruVu, Prostate cancer and the tag pipeline.
- TrialLu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Shares Lantheus and the tag pipeline.
- Trial64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Shares Lantheus and the tag pipeline.
- TrialSafety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Shares Prostate cancer and the tag pipeline.
- TrialPhase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
Shares Prostate cancer and the tag pipeline.
- TrialPhase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
Shares Prostate cancer and the tag pipeline.
- TrialEvaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Shares Prostate cancer and the tag pipeline.